VYNE Therapeutics Inc.VYNENASDAQ
Loading
Revenue ContractionContracting
Percentile Rank50
3Y CAGR+6.1%
5Y CAGR-51.4%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+6.1%/yr
vs -54.0%/yr prior
5Y CAGR
-51.4%/yr
Recent acceleration
Acceleration
+60.1pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $570000.00 | +13.8% |
| 2024 | $501000.00 | +18.2% |
| 2023 | $424000.00 | -11.1% |
| 2022 | $477000.00 | -48.8% |
| 2021 | $931000.00 | -95.6% |
| 2020 | $20.99M | +4638.8% |
| 2019 | $443000.00 | -95.8% |
| 2018 | $10.64M | +132.2% |
| 2017 | $4.58M | +579.8% |
| 2016 | $674000.00 | - |